Trapliner
Payments companies reported to CMS as associated with Trapliner. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Trapliner, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Trapliner
These are the largest totals companies reported as associated with Trapliner. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rhian Davies | York, PA | Cardiovascular Disease | $6,698.05 |
| Saroj Neupane | Detroit, MI | Internal Medicine | $633.87 |
| Ivan Pena | Louisville, KY | Interventional Cardiology | $583.99 |
| Manish Parikh | Brooklyn, NY | Internal Medicine | $367.76 |
| Ivan Pena Sing | Easton, MD | Cardiovascular Disease | $320.60 |
| Ramy Badawi | Kailua, HI | Cardiovascular Disease | $305.77 |
| Elias Haddad | Nashville, TN | Cardiovascular Disease | $253.10 |
| Raviteja Guddeti | Cincinnati, OH | Interventional Cardiology | $237.51 |
| Leah Raj | Nashville, TN | Interventional Cardiology | $197.28 |
| Tiffany Bonnecaze | Pinehurst, NC | Interventional Cardiology | $186.70 |
Prescribed Trapliner?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.